COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: FIT Biotech's cancer patent application published
17/10/2018
FIT Biotech Oy Press release 17.10.2018 at 9.45 EET FIT Biotech's cancer patent application published FIT Biotech Oy ("Company", FITBIO: FN Finland) international patent application WO 2018/185110 has now been made [...]
Patent granted in the US
17/10/2018
AroCell announced today that the U.S. Patent and Trademark Office has granted AroCell´s patent US 10,100,128 titled ”Monoclonal Anti-TK1 Antibodies”. The patent refers to AroCell’s proprietary monoclonal antibodies that [...]
IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union
17/10/2018
IMRALDI TM is approved in the European Union for the same 14 complex autoimmune conditions as its reference product In 2017 Biogen became the first company in Europe with approved biosimilars referencing the three most [...]
MDxHealth Shareholder Transparency Declaration MDxHealth (R):
17/10/2018
Press release Regulated information 16 October 2018, 7.00 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - October 16, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received [...]
MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire
17/10/2018
C ommuniqué de presse Information réglementée 17 octobre 2018, 07h00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 17 octobre 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), a annoncé avoir [...]
Nicox : Point d'activité et résumé financier du troisième trimestre 2018
17/10/2018
Communiqué de presse Nicox : Point d'activité et résumé financier du troisième trimestre 2018 Initiation d'une étude clinique de phase 2 pour NCX 470 au troisième trimestre 2018 pour la réduction de la pression [...]
Nicox Third Quarter 2018 Business Update and Financial Highlights
17/10/2018
Press Release Nicox Third Quarter 2018 Business Update and Financial Highlights NCX 470 Phase 2 clinical study initiated in Q3 2018 for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or [...]
Axiom Real-Time Metrics Exhibiting at OCT Pacific Northwest in Vancouver
17/10/2018
TORONTO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at the Outsourcing in Clinical Trials event in Vancouver, Canada October 16 [...]
Eloxx Pharmaceuticals To Report Third Quarter 2018 Financial Results and Provide Business Update On November 8, 2018
17/10/2018
Company management to host a webcast and conference call to provide a business update and review the financial results at 8:30 a.m. ET WALTHAM, Mass., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. ( [...]
Helix BioPharma Corp. Extends Period to Exercise Warrants
17/10/2018
RICHMOND HILL, Ontario, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Sirona Biochem Announces Close of Financing and Extension of Convertible Notes
17/10/2018
VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (Frankfurt: ZSB) (the “ Company ”) announced that it has closed a private placement (subject to TSX.V approval) in the [...]
AIT Therapeutics to Present High-Dose Nitric Oxide In Vitro Data at the North American Cystic Fibrosis Conference
16/10/2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Oct. 16, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
Pediapharm Announces Closing of Transformative Acquisitions, Diversifying and Expanding the Platform for Future Growth
16/10/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Oct. 16, [...]
FibroGen Announces Four Clinical Presentations on Roxadustat at Upcoming American Society of Nephrology Kidney Week 2018 Annual Meeting
16/10/2018
Roxadustat Phase 3 Clinical Results in Late-Breaking Clinical Trial Posters and Oral Presentation SAN FRANCISCO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company [...]
Ziopharm Oncology Announces Changes to Board of Directors and Management Team
16/10/2018
-- CEO Laurence Cooper Appointed to Board of Directors -- Francois Lebel to Depart Company BOSTON, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP), a biotechnology company focused on development [...]
Stratice Healthcare announces eOrdersPlus Integration with Brightree
16/10/2018
eOrdersPlus™ solution enabling direct eOrdering connectivity between healthcare professionals & providers of patients’ medical equipment, supplies and service needs now bridges last mile of electronic connectivity [...]
Bionano Genomics’ Structural Variation Results Presented at ASHG 2018 Provide Insights in Cancer and Genetic Disease
16/10/2018
SAN DIEGO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural [...]
Pacific Biosciences of California, Inc. Third Quarter 2018 Financial Results Call
16/10/2018
MENLO PARK, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2018 Financial Results on Thursday, [...]
OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Late Stage Prostate Cancer
16/10/2018
BATON ROUGE, La., Oct. 16, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Pages